FASLG and neoplasm: This may be an effect of overall tumor burden possibly due to an immunosuppressive function of the tumors, e.g. due to the production of immunosuppressive cytokines like TGFβ [41] and IL-10 [42] or the expression of Fas ligand on the tumor cell surface [43].